Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GoBBson May 08, 2020 9:17pm
127 Views
Post# 31005986

RE:RE:RE:RE:Q1 2020

RE:RE:RE:RE:Q1 2020
They have no recurring revenue to speak of, anything worthy would have come with a NR like a partnership, the sale of some other asset, the start of a placebo trial. I expect the sound of crickets with the highlight being the burn rate is down but still ridiculous...they will say we still have cash and the TV loan yet untouched but available. The only thing that matters is the BLA resubmission status ...will there be a meaningful update or more of the same "things are going well"  bull shyt .....we'll see.
<< Previous
Bullboard Posts
Next >>